Literature DB >> 14639379

Eruptive melanocytic nevi in patients with renal allografts: report of 10 cases with dermoscopic findings.

Mauro Alaibac1, Stefano Piaserico, Carlo Riccardo Rossi, Mirto Foletto, Gabriella Zacchello, Paolo Carli, Anna Belloni-Fortina.   

Abstract

Eruptive nevi have been reported after renal allograft transplantation, particularly in children and adolescents, and immunosuppression has been suggested to favor both benign and malignant melanocyte proliferation. In this study, we describe the dermoscopic features of eruptive melanocytic nevi in 10 children, adolescents, and young adults with renal allografts in whom multiple melanocytic nevi developed during a short period after transplantation. Dermoscopy of the eruptive pigmented lesions revealed a peripheral rim of brown globules. This rim of peripheral globules was present in 80% of the patients with eruptive nevi and in most of the lesions of the same patient. The other standard dermoscopic criteria for melanocytic nevi were normal. In our study, we confirm previous reports concerning the development of eruptive nevi in children and adolescents receiving immunosuppressive therapies. In particular, we showed by dermoscopy the presence of a characteristic symmetrical rim of peripheral brown globules. This finding is consistent with the hypothesis that a symmetrical peripheral rim of globules may indicate rapid enlargement of melanocytic lesions. Moreover, we have identified a new group of patients characterized by this dermoscopic feature. These patients are children, adolescents, and young adults with renal allografts receiving immunosuppressive therapy and it is plausible that this dermoscopic characteristic may be found in eruptive nevi developed in association with immunosuppression from any cause.

Entities:  

Mesh:

Year:  2003        PMID: 14639379     DOI: 10.1016/s0190-9622(03)02482-4

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

1.  Identification of BRAF mutations in eruptive melanocytic nevi: new insights into melanomagenesis?

Authors:  Jobin K John; Keiran S M Smalley
Journal:  Expert Rev Anticancer Ther       Date:  2011-05       Impact factor: 4.512

Review 2.  Melanocytic nevi and melanoma: unraveling a complex relationship.

Authors:  W E Damsky; M Bosenberg
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

3.  Sorafenib-Induced Eruptive Melanocytic Lesions.

Authors:  Hui-Chun Chen; Sheau-Chiou Chao
Journal:  Indian J Dermatol       Date:  2021 Nov-Dec       Impact factor: 1.494

4.  Cyclin D1 and D3 expression in melanocytic skin lesions.

Authors:  Ana Alekseenko; Anna Wojas-Pelc; Grzegorz J Lis; Alicja Furgał-Borzych; Grzegorz Surówka; Jan A Litwin
Journal:  Arch Dermatol Res       Date:  2010-05-23       Impact factor: 3.017

5.  [Eruptive melanocytic nevi during azathioprine therapy in myasthenia gravis].

Authors:  S A Braun; D Helbig; J Frank; S Hanneken
Journal:  Hautarzt       Date:  2012-10       Impact factor: 0.751

6.  A case with postchemotherapy eruptive compound nevus.

Authors:  Selma Bakar Dertlioglu; Muharrem Bitiren; Demet Cicek
Journal:  Indian J Dermatol       Date:  2011-11       Impact factor: 1.494

7.  Eruptive lentiginosis in resolving psoriatic plaques.

Authors:  Robert Micieli; Afsaneh Alavi
Journal:  JAAD Case Rep       Date:  2018-10-10

8.  Regulatory T Cells Play an Important Role in the Prevention of Murine Melanocytic Nevi and Melanomas.

Authors:  Laura Timares; Craig A Elmets; Tahseen H Nasti; Nabiha Yusuf; Mohammad Asif Sherwani; Mohammad Athar
Journal:  Cancer Prev Res (Phila)       Date:  2020-11-04

9.  Eruptive lentiginosis in resolving psoriatic plaques.

Authors:  Robert Micieli; Afsaneh Alavi
Journal:  JAAD Case Rep       Date:  2018-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.